Sanuwave Health (NASDAQ:SNWV) Now Covered by Northland Securities

Key Points

• Northland Securities initiated coverage of Sanuwave Health (NASDAQ:SNWV) with an "outperform" rating and a price target of $55.00, suggesting a potential upside of 38.36% from its recent close.
• Other investment analysts, including Roth Capital and Wall Street Zen, have upgraded their ratings on SNWV, indicating a consensus rating of "Buy" among market analysts.
• Sanuwave Health recently reported quarterly earnings that exceeded expectations, with revenue of $10.16 million, compared to estimates of $10.14 million.

Northland Securities initiated coverage on shares of Sanuwave Health (NASDAQ:SNWV - Get Free Report) in a research note issued on Wednesday,Briefing.com Automated Import reports. The firm set an "outperform" rating and a $55.00 price target on the stock. Northland Securities' price objective indicates a potential upside of 38.36% from the stock's previous close.

A number of other brokerages also recently issued reports on SNWV. Wall Street Zen raised Sanuwave Health from a "buy" rating to a "strong-buy" rating in a report on Saturday. Roth Capital upped their price target on Sanuwave Health from $54.00 to $55.00 and gave the stock a "buy" rating in a report on Friday, August 22nd. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Sanuwave Health currently has a consensus rating of "Buy" and an average price target of $55.00.

Sanuwave Health Price Performance

Sanuwave Health stock opened at $39.75 on Wednesday. The firm has a market cap of $340.66 million, a PE ratio of -4.82 and a beta of 1.39. Sanuwave Health has a 1-year low of $5.21 and a 1-year high of $46.58. The stock has a fifty day simple moving average of $37.08.

Sanuwave Health (NASDAQ:SNWV - Get Free Report) last posted its quarterly earnings data on Friday, August 8th. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.10. The business had revenue of $10.16 million during the quarter, compared to analyst estimates of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.

Insider Activity at Sanuwave Health

In related news, COO Peter Stegagno sold 1,862 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $27.71, for a total value of $51,596.02. Following the completion of the sale, the chief operating officer owned 2,032 shares of the company's stock, valued at approximately $56,306.72. This trade represents a 47.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 14.90% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in SNWV. Strategic Investment Solutions Inc. IL purchased a new position in Sanuwave Health in the first quarter worth approximately $47,000. Solas Capital Management LLC purchased a new position in Sanuwave Health in the first quarter valued at $20,658,000. AWM Investment Company Inc. purchased a new position in Sanuwave Health in the first quarter valued at $18,153,000. Goldman Sachs Group Inc. purchased a new position in Sanuwave Health in the first quarter valued at $337,000. Finally, Evernest Financial Advisors LLC purchased a new position in Sanuwave Health in the second quarter valued at $823,000. 42.53% of the stock is currently owned by hedge funds and other institutional investors.

Sanuwave Health Company Profile

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.